FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Avella of Deer Valley, Inc. Store 38 0.2% ROPivacaine Recall

0.2% ROPivacaine - OnQ Pump, (ROPivacaine HCL (USP) 1100mg, 0.9% Sodium Chloride (USP)…

Avella of Deer Valley, Inc. Store 38 · Phoenix, AZ

Risk level
Class II
Reported by FDA
Jul 25, 2018
Recall ID
D-0928-2018
Check your lot numberHow we source this data

Summary

Avella of Deer Valley, Inc. Store 38 recalled 0.2% ROPivacaine starting Jun 12, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0928-2018 on Jul 25, 2018. Reason: Lack of Assurance of Sterility: Potential leakage of bags. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Potential leakage of bags.

Product description

0.2% ROPivacaine - OnQ Pump, (ROPivacaine HCL (USP) 1100mg, 0.9% Sodium Chloride (USP) QS 550 ml, single dose pump. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77056. NDC: 42852-661-02

Lot numbers, UPCs & expiration codes

Lot # 5/14/18 0749 525-66102, BUD 6/13/2018; 5/22/18 0837 495-66102, BUD 6/21/2018

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0928-2018
Classification
Class II
Status
Terminated
Recall initiated
Jun 12, 2018
FDA report date
Jul 25, 2018
Quantity
40 pumps
Recall type
Voluntary: Firm initiated
Recalling firm
Avella of Deer Valley, Inc. Store 38

Original FDA data

Every field from FDA enforcement report D-0928-2018, exactly as published.

Show all FDA fields
City
Phoenix
State
AZ
Status
Terminated
Country
United States
Event ID
80307
Address
24416 N 19th Ave
Code information
Lot # 5/14/18 0749 525-66102, BUD 6/13/2018; 5/22/18 0837 495-66102, BUD 6/21/2018
Postal code
85085-1887
Report date
Jul 25, 2018
Product type
Drugs
Recall number
D-0928-2018
Classification
Class II
Recalling firm
Avella of Deer Valley, Inc. Store 38
Product quantity
40 pumps
Termination date
Jan 24, 2020
Reason for recall
Lack of Assurance of Sterility: Potential leakage of bags.
Voluntary / mandated
Voluntary: Firm initiated
Product description
0.2% ROPivacaine - OnQ Pump, (ROPivacaine HCL (USP) 1100mg, 0.9% Sodium Chloride (USP) QS 550 ml, single dose pump. For: Vidant Medical Center, By: Avella of Houston, 9265 Kirby Dr., Houston, TX 77056. NDC: 42852-661-02
Distribution pattern
Nationwide in the USA
Recall initiation date
Jun 12, 2018
Initial firm notification
Letter
Center classification date
Jul 19, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0928-2018, published Jul 25, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls